{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:49:08Z","timestamp":1760622548852},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ijantimicag.2006.08.043","type":"journal-article","created":{"date-parts":[[2006,12,23]],"date-time":"2006-12-23T12:14:17Z","timestamp":1166876057000},"page":"56-61","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis"],"prefix":"10.1016","volume":"29","author":[{"given":"Marcus","family":"Zervos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy W.","family":"Amsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance D.","family":"Rothermel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Treadway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.08.043_bib1","unstructured":"American Thoracic Society and European Respiratory Society Position Paper. Standards for the diagnosis and management of patients with COPD. http:\/\/www.thoracic.org\/copd [accessed 6 June 2005]."},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib2","unstructured":"World Health Organization. The global burden of disease. http:\/\/www.who.int\/mip\/2003\/other_documents\/en\/globalburdenofdisease.pdf [accessed 26 May 2005]."},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-134-7-200104030-00015","article-title":"Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease","volume":"134","author":"Snow","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib5","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1185\/030079904X3096","article-title":"Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem","volume":"20","author":"Sethi","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib6","first-page":"1204","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"48","author":"Wedzicha","year":"2003","journal-title":"Respir Care"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib7","series-title":"Principles and practice of infectious diseases","article-title":"Chronic bronchitis and acute infectious exacerbations","author":"Reynolds","year":"2000"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.273.12.957","article-title":"Antibiotics in chronic obstructive pulmonary disease: a meta-analysis","volume":"273","author":"Saint","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2006.08.043_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jac\/43.suppl_1.107","article-title":"Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis","volume":"43","author":"Destache","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib12","series-title":"Package insert","author":"Zithromax","year":"2004"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00151829-200504010-00004","article-title":"Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomised study","volume":"4","author":"Swanson","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1378\/chest.123.3.772","article-title":"Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis","volume":"123","author":"Amsden","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/374052","article-title":"Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998\u20132002)","volume":"36","author":"Karlowsky","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib18","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth Informational Supplement. M100-S9. Wayne, PA: NCCLS; 1999."},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2006.08.043_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/43.suppl_1.97","article-title":"Infectious exacerbations of chronic bronchitis: diagnosis and management","volume":"43","author":"Sethi","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib20","first-page":"33","article-title":"A comparison of moxifloxacin and azithromycin in the treatment of acute exacerbations of chronic bronchitis","volume":"7","author":"Kreis","year":"2000","journal-title":"J Clin Outcomes Manag"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.1.1","article-title":"Pneumococcal macrolide resistance \u2014 myth or reality?","volume":"44","author":"Amsden","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.43.1.163","article-title":"Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1500milligrams, given over a 3- or 5-day period in healthy subjects","volume":"43","author":"Amsden","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2006.08.043_bib23","doi-asserted-by":"crossref","first-page":"A4","DOI":"10.1016\/j.curtheres.2003.09.004","article-title":"Single-dose azithromycin for acute otitis media: a pharmacokinetic\/pharmacodynamic rationale","volume":"64","author":"Rothermel","year":"2003","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/317502","article-title":"Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Italy, 1997\u20131999","volume":"31","author":"Pantosti","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/JCM.43.3.1294-1300.2005","article-title":"Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe","volume":"43","author":"Reinert","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.08.043_bib27","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/379709","article-title":"Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991\u20132000","volume":"37","author":"Zervos","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906004080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906004080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T10:17:19Z","timestamp":1556014639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906004080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0924857906004080"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.08.043","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}